Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Social Anxiety MDMA-Assisted Therapy Investigation (SAMATI): A Randomized, Delayed Treatment Control Phase 2 Study of the Safety and Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Social Anxiety Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05138068

Organisation Name: Portland Psychotherapy Clinic, Research, and Training Center

Overal Status: Recruiting

Start Date: April 13, 2022

Last Update: June 22, 2022

Lead Sponsor: Jason B Luoma

Brief Summary: This is a randomized, open-label delayed treatment study to assess the safety and effect of MDMA-assisted therapy in treating 20 participants diagnosed with moderate-to-severe social anxiety disorder (SAD) of the generalized subtype. This study will obtain an estimate of effect size for two experimental sessions of MDMA-assisted therapy for the treatment of social anxiety disorder on measures of safety, social anxiety, functional outcomes, psychiatric symptoms, and putative mechanisms of action. The primary outcome for this study will be the Liebowitz Social Anxiety Scale (LSAS) administered by a blinded Independent Rater (IR). Other assessments, including physiological, self-report, and behavioral tasks will be used to assess other exploratory variables. An additional aim of the trial will be the development of a treatment manual for MDMA-AT for SAD for future research.

Conditions:
  • Social Anxiety Disorder


Total execution time in seconds: 0.46015691757202